about
Therapeutic Approach to Adult Fibrotic Lung DiseasesRecent Treatments of Interstitial Lung Disease with Systemic SclerosisUpdate on biomarkers in systemic sclerosis: tools for diagnosis and treatmentCharacterisation of patients with interstitial pneumonia with autoimmune features.Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese malesSpectrum of diffuse parenchymal lung diseases with special reference to idiopathic pulmonary fibrosis and connective tissue disease: An eastern India experienceReview: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic SclerosisAssociation of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosisQuantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis.Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis.An explanatory model of functional exercise capacity in patients with systemic sclerosis: considerations for rehabilitation programs.Pulmonary involvement in systemic sclerosis: A clinical profile.Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model.Scleroderma-related interstitial lung disease.Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study.Interstitial lung disease in South Africans with systemic sclerosis.Sarcoidosis and Systemic Sclerosis: Strange Bedfellows.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis.Evaluation and management approaches for scleroderma lung disease.Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment.Effectiveness of Thoracic Ultrasonography in the Evaluation of the Severity of Pulmonary Involvement in Patients With Systemic SclerosisInterstitial lung disease in systemic sclerosis: challenges in early diagnosis and management
P2860
Q26741569-650CA1DB-FF31-4E84-AE9C-D6C637CBD2DAQ26773161-FB92EE95-970C-4A51-8DF8-988B33741CC4Q26995542-4B667395-7ECF-4A5F-994A-8F8506A9E398Q33915673-511D787F-2398-435C-8488-959162DB6D8FQ34046860-7DBF110C-D6F2-4D18-8037-37156DC37A18Q34453106-C71405FB-7650-4DC8-BF9A-C525BD03F627Q35121494-B97D0224-8739-4F69-82C1-9E2F632802BDQ35777021-3A692C3B-2D4D-40B5-9BF7-929632D29701Q35941472-8999B7FD-35D9-4C14-8CF1-D1AEADC50DF2Q36114308-A978B458-45C5-48B9-B59C-64DD50A6414BQ36364258-D7602CDD-4D9B-4B22-B18A-A962086AF896Q36642268-E361A71F-E9D4-46DB-88E9-DEAE73D3FCB9Q36685226-7BF90C12-BF3E-4D9A-8400-9B8CEA60B0FBQ36690377-142B2390-4D66-4929-8D46-8A8ACD2584BDQ36701466-59490396-4ED4-4623-A809-F77DF2EF3C97Q37690737-68682CB1-4F92-424A-B686-81AA619FEE0FQ38793513-74DF3880-ED3E-4A32-8E15-D134021D3B75Q40153822-55F02DC3-E333-4EC6-8766-9E3747570E7AQ41105228-ABBC1DC2-178E-4D26-813D-9CC22ED4387BQ45167705-426D06CA-0A24-485C-994F-FFA9B3F1A368Q46176565-C0E08EA6-2C7E-4ADE-9AC9-72AC48721010Q47662880-05ACB374-FFD2-4998-963A-4DF688AF411DQ49072027-6DE5E996-5366-40A8-9A69-B0739EEEDAD8Q50097908-50ED07BE-B3F0-42FD-BADE-083A57F936D6Q50660360-8178521E-C504-4D0E-82E6-37FE00FC2E13Q52939870-44ABED3C-A151-4449-A373-80C6EF3C76AFQ55361229-A563DD32-C2F5-49A2-92FE-1A88DDA103D6Q58134790-E4665418-FCDA-4D15-AB94-96718B168FFEQ58779775-512E3532-7343-4D04-9E54-74AB5DD9BBFE
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Scleroderma lung disease
@ast
Scleroderma lung disease
@en
type
label
Scleroderma lung disease
@ast
Scleroderma lung disease
@en
prefLabel
Scleroderma lung disease
@ast
Scleroderma lung disease
@en
P2093
P2860
P1476
Scleroderma lung disease
@en
P2093
Amy L Olson
Aryeh Fischer
Ganesh Raghu
Joshua J Solomon
Kevin K Brown
P2860
P356
10.1183/09059180.00005512
P577
2013-03-01T00:00:00Z